Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial.
Raphael J LandovitzSue LiBeatriz Gilda Jegerhorn GrinsztejnHalima DawoodAlbert Y LiuManya MagnusMina C HosseinipourRavindre PanchiaLeslie CottleGordon ChauPaul RichardsonMark A MarzinkeCraig W HendrixSusan H EshlemanYinfeng ZhangElizabeth Ellen TolleyJeremy SugarmanRyan KofronAdeola AdeyeyeDavid BurnsAlex R RinehartDavid MargolisWilliam R SpreenMyron S CohenMarybeth McCauleyJoseph J EronPublished in: PLoS medicine (2018)
ClinicalTrials.gov Registry: ClinicalTrials.gov Trial number: NCT02178800.
Keyphrases